COTTON-WOOL SPOTS AFTER USE OF MACITENTAN FOR PULMONARY ARTERIAL HYPERTENSION

Retin Cases Brief Rep. 2017;11(1):4-6. doi: 10.1097/ICB.0000000000000273.

Abstract

Purpose: To report a case of transient, bilateral cotton spots after initiation of macitentan, an endothelin receptor antagonist used for the treatment of pulmonary arterial hypertension.

Methods: Case report.

Results: A 76-year-old woman with WHO Class IIIb pulmonary arterial hypertension was referred for evaluation of bilateral cotton-wool spots 1 week after starting macitentan therapy. The patient was asymptomatic and visual acuity was 20/25 in each eye. Fluorescein angiography and optical coherence tomography were completed. Given lack of symptoms and alternative treatment options, the patient was observed closely. The cotton-wool spots resolved 8 weeks after presentation and visual acuity remained stable at 20/25. Throughout the observation period, average mean arterial pressure was within normal limits at 84.8.

Conclusion: In patients using endothelin receptor antagonists, medication side effect should be considered in the differential diagnosis of cotton-wool spots.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Endothelin A Receptor Antagonists / adverse effects*
  • Female
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Pyrimidines / adverse effects*
  • Retinal Diseases / chemically induced*
  • Retinal Diseases / diagnostic imaging
  • Sulfonamides / adverse effects*

Substances

  • Endothelin A Receptor Antagonists
  • Pyrimidines
  • Sulfonamides
  • macitentan